55390-084 : Mitoxantrone 2 mg/ml Intravenous Injection, Solution


NDC: 55390-084
Labeler: Bedford Laboratories
Product Type: Human Prescription Drug
Drug Name:  Mitoxantrone
Dosage Form: Intravenous Injection, Solution
Application #: ANDA076611
Rev. Date: 


NDC Package Codes:

  • 55390-084-01: 1 VIAL, MULTI‑DOSE IN 1 BOX (55390‑084‑01) > 12.5 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Mitoxantrone

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 55390-083 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 55390-085 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
  • 0703-4680 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4685 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 0703-4686 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
  • 61703-343 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Hospira Worldwide, Inc.
  • 63323-132 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by App Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55390-084 QR Code

< Prev: 55390-083Next: 55390-085 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.